Legend Biotech Corporation, a leader in cell therapy, is set to host a live webcast for investors on June 1, 2025, during the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. The event will feature Ying Huang, Ph.D., CEO, and Mythili Koneru, M.D., Ph.D., CMO, alongside expert clinicians who will present the latest updates from the CARTITUDE development program.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.